UBS Group’s Burning Rock Biotech BNR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.24K | Buy |
709
+599
| +545% | +$1.89K | ﹤0.01% | 8173 |
|
|
2025
Q1 | $495 | Sell |
110
-1,320
| -92% | -$5.94K | ﹤0.01% | 8440 |
|
|
2024
Q4 | $9.65K | Sell |
1,430
-2,815
| -66% | -$19K | ﹤0.01% | 7109 |
|
|
2024
Q3 | $13.9K | Buy |
4,245
+1,665
| +65% | +$5.44K | ﹤0.01% | 6355 |
|
|
2024
Q2 | $16.6K | Buy |
2,580
+2,572
| +32,150% | +$16.6K | ﹤0.01% | 6272 |
|
|
2024
Q1 | $60 | Buy |
+8
| New | +$60 | ﹤0.01% | 7731 |
|
|
2023
Q4 | – | Sell |
-173
| Closed | -$1.67K | – | 8091 |
|
|
2023
Q3 | $1.67K | Buy |
+173
| New | +$1.67K | ﹤0.01% | 6711 |
|
|
2023
Q2 | – | Sell |
-292
| Closed | -$8.19K | – | 7837 |
|
|
2023
Q1 | $8.19K | Buy |
292
+105
| +56% | +$2.95K | ﹤0.01% | 6651 |
|
|
2022
Q4 | $4.22K | Buy |
+187
| New | +$4.22K | ﹤0.01% | 8164 |
|
|
2022
Q3 | – | Sell |
-3,172
| Closed | -$93K | – | 9215 |
|
|
2022
Q2 | $93K | Buy |
3,172
+2,922
| +1,169% | +$85.7K | ﹤0.01% | 4483 |
|
|
2022
Q1 | $23K | Buy |
250
+114
| +84% | +$10.5K | ﹤0.01% | 6240 |
|
|
2021
Q4 | $13K | Sell |
136
-7,460
| -98% | -$713K | ﹤0.01% | 7313 |
|
|
2021
Q3 | $1.36M | Buy |
7,596
+591
| +8% | +$106K | ﹤0.01% | 3026 |
|
|
2021
Q2 | $2.06M | Buy |
+7,005
| New | +$2.06M | ﹤0.01% | 2716 |
|
|
2021
Q1 | – | Sell |
-41
| Closed | -$9K | – | 7923 |
|
|
2020
Q4 | $9K | Buy |
+41
| New | +$9K | ﹤0.01% | 6525 |
|
|
2020
Q3 | – | Sell |
-329
| Closed | -$89K | – | 7082 |
|
|
2020
Q2 | $89K | Buy |
+329
| New | +$89K | ﹤0.01% | 4564 |
|